These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 26629967)

  • 1. Safety evaluation of chemically modified beta-lactoglobulin administered intravaginally.
    Guo X; Qiu L; Wang Y; Wang Y; Meng Y; Zhu Y; Lu L; Jiang S
    J Med Virol; 2016 Jun; 88(6):1098-101. PubMed ID: 26629967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemically modified bovine beta-lactoglobulin inhibits human papillomavirus infection.
    Lu L; Yang X; Li Y; Jiang S
    Microbes Infect; 2013 Jun; 15(6-7):506-10. PubMed ID: 23518265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized open-label clinical trial of an anti-HPV biological dressing (JB01-BD) administered intravaginally to treat high-risk HPV infection.
    Guo X; Qiu L; Wang Y; Wang Y; Wang Q; Song L; Li Y; Huang K; Du X; Fan W; Jiang S; Wang Q; Li H; Yang Y; Meng Y; Zhu Y; Lu L; Jiang S
    Microbes Infect; 2016 Feb; 18(2):148-52. PubMed ID: 26506570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bovine beta-lactoglobulin modified by 3-hydroxyphthalic anhydride blocks the CD4 cell receptor for HIV.
    Neurath AR; Jiang S; Strick N; Lin K; Li YY; Debnath AK
    Nat Med; 1996 Feb; 2(2):230-4. PubMed ID: 8574970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new mode of treatment of human papilloma virus associated anogenital lesions using a nonsteroid estrogen analogue.
    Schön HJ; Grgurin M; Szekeres T; Schurz B
    Wien Klin Wochenschr; 1996; 108(2):45-7. PubMed ID: 8835432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced mucosal and systemic immune responses following intravaginal immunization with human papillomavirus 16 L1 virus-like particle vaccine in thermosensitive mucoadhesive delivery systems.
    Park JS; Oh YK; Kang MJ; Kim CK
    J Med Virol; 2003 Aug; 70(4):633-41. PubMed ID: 12794729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus (HPV): systemic treatment with Gene-Eden-VIR/Novirin safely and effectively clears virus.
    Polansky H; Itzkovitz E; Javaherian A
    Drug Des Devel Ther; 2017; 11():575-583. PubMed ID: 28424535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral therapy and the clinical evolution of human papillomavirus-associated genital lesions in HIV-positive women.
    Del Mistro A; Bertorelle R; Franzetti M; Cattelan A; Torrisi A; Giordani MT; Sposetti R; Bonoldi E; Sasset L; Bonaldi L; Minucci D; Chieco-Bianchi L
    Clin Infect Dis; 2004 Mar; 38(5):737-42. PubMed ID: 14986260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical imiquimod treatment for human papillomavirus infection in patients with and without cervical/vaginal intraepithelial neoplasia.
    Lin CT; Qiu JT; Wang CJ; Chang SD; Tang YH; Wu PJ; Jung SM; Huang CC; Chou HH; Jao MS; Lai CH
    Taiwan J Obstet Gynecol; 2012 Dec; 51(4):533-8. PubMed ID: 23276555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Underlying Mechanism of 3-Hydroxyphthalic Anhydride-Modified Bovine Beta-Lactoglobulin to Block Human Papillomavirus Entry Into the Host Cell.
    Hua C; Zhu Y; Wu C; Si L; Wang Q; Sui L; Jiang S
    Front Microbiol; 2019; 10():2188. PubMed ID: 31611852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary note on the use of interferon alpha by peroral route in HPV lesions.
    Montevecchi L; Caprio G; Vecchione A
    Clin Ter; 2000; 151(1 Suppl 1):29-34. PubMed ID: 10876964
    [No Abstract]   [Full Text] [Related]  

  • 12. Peroral alpha-interferon therapy in HPV-lesions of the lower female genital tract: preliminary results.
    Biamonti A; Cangialosi M; Brozzo R; Vecchione A; Serra GB
    Clin Ter; 2000; 151(1 Suppl 1):53-8. PubMed ID: 10876966
    [No Abstract]   [Full Text] [Related]  

  • 13. Potential risk factors associated with the use of cidofovir to treat benign human papillomavirus-related disease.
    Donne AJ; Hampson L; He XT; Day PJ; Salway F; Rothera MP; Homer JJ; Hampson IN
    Antivir Ther; 2009; 14(7):939-52. PubMed ID: 19918098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I clinical trial of repeat dose terameprocol vaginal ointment in healthy female volunteers.
    Khanna N; Dalby R; Connor A; Church A; Stern J; Frazer N
    Sex Transm Dis; 2008 Jun; 35(6):577-82. PubMed ID: 18418294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary assessment of potential toxicity of methylated soybean protein and methylated β-lactoglobulin in male Wistar rats.
    Sitohy M; Osman A; Gharib A; Chobert JM; Haertlé T
    Food Chem Toxicol; 2013 Sep; 59():618-25. PubMed ID: 23835286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antiviral activity of 3-hydroxyphthalic anhydride-modified ovalbumin against herpes simplex virus 2 in vitro].
    He LL; Duan JM; Qiu JY; Yu F; Liu SW; Li L
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jun; 31(7):1175-8. PubMed ID: 21764688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPV proteins as targets for therapeutic intervention.
    Sterlinko Grm H; Banks L
    Antivir Ther; 2004 Oct; 9(5):665-78. PubMed ID: 15535404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy of cryotherapy combined with interferon in the treatment of chronic cervicitis complicated with HPV infection.
    Su Y; Zhang M; Zhang W; Shi H
    Pak J Pharm Sci; 2017 Jul; 30(4(Suppl.)):1505-1508. PubMed ID: 29044006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical vidarabine or 5-fluorouracil treatment against persistent HPV in genital (pre)cancerous lesions.
    Niwa K; Tagami K; Lian Z; Gao J; Mori H; Tamaya T
    Oncol Rep; 2003; 10(5):1437-41. PubMed ID: 12883720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the development of ribozymes and antisense oligodeoxynucleotides as antiviral agents for human papillomaviruses.
    Alvarez-Salas LM; Benítez-Hess ML; DiPaolo JA
    Antivir Ther; 2003 Aug; 8(4):265-78. PubMed ID: 14518695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.